Waystar Holding Corp. (WAY) Gets a Buy from Barclays
Barclays analyst Glen Santangelo maintained a Buy rating on Waystar Holding Corp. (WAY) with a price target of $25.00. This rating is consistent with the Street's Strong Buy consensus, which has an average price target of $34.21. Waystar's latest quarterly earnings showed strong growth, with revenues of $313.87 million and a net profit of $43.28 million.
Analysts’ Top Technology Picks: Waystar Holding Corp. (WAY), Palo Alto Networks (PANW)
Analysts have issued bullish sentiments on Waystar Holding Corp. (WAY) and Palo Alto Networks (PANW). Ryan Daniels from William Blair maintained a Buy rating on Waystar with an average price target indicating an 89.5% upside. Shaul Eyal from TD Cowen reiterated a Buy rating on Palo Alto Networks, with a price target of $255.00.
Waystar to Speak at William Blair Conference
Waystar Holding Corp. (WAY) is scheduled to speak at the William Blair Conference. This announcement was released via a press release and alerted to Quantisnow Plus members shortly after publication. Quantisnow, a market data and news platform, provides real-time alerts on various company events, including press releases.
Waystar CEO Matt Hawkins to speak at William Blair growth conference
Waystar (Nasdaq: WAY) announced that CEO Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on June 2, 2026, at 10:40 a.m. CT. A live webcast and post-event recording will be available on Waystar’s investor relations website, providing investors with an opportunity to hear updates on the company's performance, capital allocation, and product adoption. Waystar's recent history shows strong fundamentals, AI product initiatives, and a significant share repurchase authorization, but market reactions have been mixed.
Waystar to Speak at William Blair Conference
Waystar Holding Corp. (Nasdaq: WAY) announced that CEO Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on June 2, 2026, at 10:40 a.m. CT. A live webcast and subsequent recording of the presentation will be available on the company's Investor Relations website. Waystar specializes in healthcare payment software, serving over 30,000 clients and processing billions in transactions annually.
Waystar to Speak at William Blair Conference
Waystar Holding Corp. announced that CEO Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on June 2, 2026, at 10:40 a.m. CT. A live webcast and subsequent recording of the presentation will be available on the company's Investor Relations website. Waystar specializes in healthcare payment software, serving over 30,000 clients and processing significant healthcare payment transactions annually.
Waystar sets $200M stock repurchase plan
Waystar (WAY) has announced a significant stock repurchase program, authorizing the company to buy back up to $200 million of its outstanding common stock. This move indicates Waystar's confidence in its financial health and could be a strategy to return value to shareholders and potentially boost the stock price. The repurchase plan reflects management's belief that the company's shares are undervalued.
Waystar sets $200M stock repurchase plan
The article states that Waystar has approved a $200 million stock repurchase program. This plan indicates the company's confidence in its financial position and could potentially increase shareholder value by reducing the number of outstanding shares. This move suggests management believes the stock is undervalued.
Waystar (WAY) Sees 7% Rise in Stock Price
Waystar (WAY) experienced a 7% increase in its stock price, reaching $19.84, reflecting positive market sentiment following a period of volatility. Despite a premium P/E ratio of 29.46x, its GuruFocus GF Score™ is low at 18/100, indicating potential challenges for strong long-term returns. Investors are advised to consider the company's financial health, including moderate financial strength (5/10) and low profitability (4/10), even with recent insider buying activity.
$200M share buyback at healthcare payment software firm Waystar
Waystar (Nasdaq: WAY) announced that its Board of Directors authorized a stock repurchase plan for up to $200 million of the company's common stock, reflecting confidence in its long-term growth and recurring free cash flow. The repurchases may occur over time through various methods and are discretionary, allowing the company to suspend or discontinue the plan at any time. CEO Matt Hawkins stated that this authorization provides flexibility to repurchase shares in a disciplined, valuation-focused way as market conditions permit, aligning with their capital allocation priorities.
Waystar authorizes $200 million stock buyback program By Investing.com
Waystar Holding Corp. has announced a $200 million stock repurchase program, reflecting the Board's confidence in the company's long-term growth and free cash flow generation. The healthcare payment software provider's stock is currently trading near its 52-week low and is considered undervalued by InvestingPro analysis, despite recent positive Q1 fiscal 2026 earnings that surpassed revenue expectations. Analysts have maintained mostly positive ratings, with varying price targets.
Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook
Waystar Holding Corp. announced a $200 million stock repurchase plan authorized by its Board of Directors, signaling confidence in the company's long-term growth and financial health. The repurchases will be made through various methods, depending on market conditions, and align with Waystar's strategy to invest in innovation, maintain a strong balance sheet, and return excess capital to enhance per-share value. The company, a healthcare payment software provider, emphasized its commitment to product innovation and commercial execution.
(WAY) and the Role of Price-Sensitive Allocations
This article analyzes Waystar Holding Corp. (NYSE: WAY) using AI models, highlighting weak sentiment across all horizons and suggesting a short bias. It details three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss points. The analysis also provides multi-timeframe signal support and resistance levels.
Waystar Holding Corp. (WAY) Stock Analysis: Assessing The 93.75% Upside Potential
Waystar Holding Corp. (WAY), a healthcare payments software provider, is attracting significant attention with a potential upside of 93.75% based on analyst ratings. The company, which boasts robust revenue growth and strong cash flow, operates in the Health Information Services industry. Despite short-term bearish technical indicators, its strong fundamentals and favorable analyst consensus make it an attractive prospect for growth-oriented investors.
Waystar Holding Corp. engages attendees at Florida HFMA Spring Conference with expert insights and giveaway
Waystar Holding Corp. is actively participating in the Florida HFMA Spring Conference, offering industry expertise and an interactive engagement at booth 14, including a Nike sneaker giveaway. The company aims to connect face-to-face with industry professionals and provide real-time answers to revenue cycle questions. Waystar has previously emphasized unified mid-cycle integration in healthcare and successfully helped OSF HealthCare improve query rates and financial performance.
SmallCap Growth Fund I's Waystar Holding Corp(WAY) Holding History
This article details SmallCap Growth Fund I's historical holdings in Waystar Holding Corp (WAY). As of January 31, 2026, PRINCIPAL FUNDS INC held 9,579 shares of WAY, constituting 0.01% of their portfolio. The fund has made six purchases and one sale of WAY shares, resulting in an estimated loss of $1.54 million or -15.38% on their current holdings.
Waystar Holding Corp. empowers staff with advanced AI to cut denials by nearly 78 percent
Waystar Holding Corp. announced that OSF HealthCare achieved a nearly 78% reduction in patient denials by integrating Waystar's advanced automation and AI into its patient access processes. This improvement resulted from replacing manual frontend procedures and empowering staff, leading to enhanced financial performance and more effective denial prevention. Waystar continues to develop AI-driven revenue cycle management innovations to streamline healthcare operations and reduce manual work for providers.
Waystar Holding stock (US94419L1017): Healthcare IT leader reports strong fiscal 2026 results
Waystar Holding, a leading healthcare IT company, has reported strong fiscal 2026 performance ahead of its annual shareholder meeting on June 25, 2026. The company specializes in cloud-based revenue cycle management solutions, which are critical for streamlining billing and claims processes in the U.S. healthcare industry. Waystar's business model leverages recurring SaaS subscriptions and transaction-based fees, positioning it to benefit from the ongoing digitalization and modernization of healthcare systems.
Number of employees of Waystar Holding Corp. – LSX:A3EXMR
This article focuses on the number of employees of Waystar Holding Corp., traded on the Lang & Schwarz Exchange under the symbol A3EXMR. It appears to be a stub or a placeholder page from TradingView, indicating that specific employee count data would typically be displayed here, alongside other financial information, news, and community discussions.
ETFs Investing in Waystar Holding Corp. Stocks
This article lists various ETFs that currently hold Waystar Holding Corp. (WAY) stocks. It provides a detailed table including each ETF's market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV total return. The ETFs predominantly invest in small-cap companies, with some focusing on healthcare or extended market segments.
Waystar Holding Corp. Cash Flow – LSX:A3EXMR
This article provides key financial data for Waystar Holding Corp. (A3EXMR) focusing on its cash flow. It highlights that the free cash flow for Q1 2026 was €60.23 million, and for the full year 2025, it was €241.12 million, with operating cash flow at €263.66 million. The data is presented with historical figures and breakdown of cash activities from 2021 to 2025.
Net income of Waystar Holding Corp. – LSX:A3EXMR
The article focuses on the net income of Waystar Holding Corp., identified by the ticker symbol LSX:A3EXMR on the Lang & Schwarz Exchange. It highlights the company's financial overview, suggesting users can find detailed financials, community discussions, and forecasts on the platform. The content is primarily a listing of company information and navigation links from the TradingView platform.
Waystar Holding Corp stock hits 52-week low at $19.77 By Investing.com
Waystar Holding Corp (WAY) stock has fallen to a 52-week low of $19.77, a 53% drop from its high despite a "Strong Buy" analyst consensus and an InvestingPro Fair Value suggesting potential upside. The company recently surpassed Q1 fiscal 2026 revenue expectations but maintained its full-year guidance, leading to varied analyst reactions.
Waystar Holding Corp stock hits 52-week low at $19.77 By Investing.com
Waystar Holding Corp (WAY) stock has fallen to a 52-week low of $19.78, a 53% drop from its high, despite analysts maintaining a "Strong Buy" consensus with significant upside potential. InvestingPro analysis suggests the stock is undervalued with a fair value of $28.04. The healthcare payments company recently reported strong first-quarter fiscal 2026 earnings, surpassing revenue expectations, and sustaining a "GREAT" financial health score.
Waystar Holding Drops 6.2% Amid Sector-Wide Selling
Waystar Holding Corp. experienced a 6.2% decline, dropping to $20.06, as a broad selloff impacted health information services stocks. This sector-wide movement was not triggered by company-specific news for Waystar but rather by contagion, with several peers also seeing significant drops, including Certara which plunged 13.5%. The decline is attributed to broader positioning shifts and a cautious analyst sentiment, prompting investors to monitor a potential reassessment of growth expectations and macro concerns affecting healthcare technology.
Price to cash flow ratio of Waystar Holding Corp. – LS:A3EXMR
This article provides financial information for Waystar Holding Corp. (LS:A3EXMR), specifically focusing on its price to cash flow ratio. It appears to be a stub or data-oriented page from TradingView, indicating that market data is provided by ICE Data Services and reference data by FactSet.
Price to earnings ratio of Waystar Holding Corp. – LS:A3EXMR
This article provides financial information for Waystar Holding Corp., specifically focusing on its price-to-earnings ratio. It references data from TradingView, FactSet, and ICE Data Services, indicating a focus on financial metrics for the company with the ticker LS:A3EXMR.
Gross profit of Waystar Holding Corp. – LS:A3EXMR
This article provides financial information for Waystar Holding Corp. (LS:A3EXMR), specifically focusing on its gross profit. The content indicates that the market is closed and directs users to overview financial data, community features, forecasts, and ETFs for the company.
Diluted net income available to common stockholders of Waystar Holding Corp. – LS:A3EXMR
The article provides a snapshot of the diluted net income available to common stockholders of Waystar Holding Corp. (LS:A3EXMR) within the TradingView platform. It shows that the market is currently closed and presents basic financial information without specific values. The content appears to be a stub or a placeholder for detailed financial data.
Average basic shares outstanding of Waystar Holding Corp. – LS:A3EXMR
The article provides a financial data point for Waystar Holding Corp. (LS:A3EXMR), specifically focusing on its average basic shares outstanding. It lists the company's identifier and indicates that this information can be found within the financial section of a trading platform.
Gross margin % of Waystar Holding Corp. – LS:A3EXMR
This article provides financial data for Waystar Holding Corp. (LS:A3EXMR), specifically focusing on its gross margin percentage. It details how to access this information through TradingView, emphasizing the company's financial performance metrics.
Tangible book value per share of Waystar Holding Corp. – LS:A3EXMR
This article provides financial data for Waystar Holding Corp. (LS:A3EXMR), specifically focusing on its tangible book value per share. It highlights that the market for this stock is currently closed and presents various data points related to its financial performance.
Taxes of Waystar Holding Corp. – LS:A3EXMR
This page provides financial data related to the taxes of Waystar Holding Corp. (LS:A3EXMR) on TradingView. It indicates that the market is currently closed and presents a basic overview of the company's financial information without specific tax figures in the displayed content. The article is primarily a placeholder for financial data, offering access to various services and tools on the TradingView platform.
Quick ratio of Waystar Holding Corp. – LS:A3EXMR
This article provides financial information for Waystar Holding Corp. (LS:A3EXMR) on TradingView. It specifically highlights the quick ratio of the company. The page also offers various financial tools, market data, and community features related to trading and investment.
Waystar Holding Corp. Income Statement – LS:A3EXMR
Waystar Holding Corp.'s income statement shows the company's financial performance, with the latest quarter (Q1 26) reporting a total revenue of 271.67 million EUR, a 5.12% increase from the previous quarter, and a net income of 37.46 million EUR. The article provides a detailed historical overview of key financial metrics, such as total revenue, gross profit, operating income, and net income, for the years 2021 through 2025. It also includes sections for balance sheet and cash flow statements, available in both annual and quarterly views.
Did Strong Q1 Results and TIME100 AltitudeAI Recognition Just Shift Waystar Holding's (WAY) Investment Narrative?
Waystar Holding Corp. recently reported strong Q1 2026 results, including US$313.87 million in revenue and US$43.28 million in net income, and reaffirmed its full-year revenue guidance. The company also received recognition from TIME100 for its AltitudeAI platform, highlighting its growing influence in healthcare revenue cycle automation. While these developments support confidence in near-term execution, investors are advised to consider risks related to integration, debt, and potential margin pressures.
Number of shareholders of Waystar Holding Corp. – NASDAQ:WAY
This article provides details about Waystar Holding Corp. (NASDAQ: WAY), specifically focusing on its shareholder information as available on TradingView. It indicates that the period value and change percentages for the number of shareholders are available and that the market for the stock is currently closed.
Did Strong Q1 Results and TIME100 AltitudeAI Recognition Just Shift Waystar Holding's (WAY) Investment Narrative?
Waystar Holding Corp. reported strong first-quarter 2026 results with US$313.87 million in revenue and US$43.28 million in net income, and reaffirmed its full-year 2026 revenue guidance. The company also gained recognition for its AltitudeAI platform on the TIME100 Most Influential Companies list, highlighting its growing role in healthcare revenue cycle automation. While these developments bolster confidence in Waystar's near-term execution, investors are advised to consider ongoing risks related to integration, debt, and potential margin pressure.
Did Strong Q1 Results and TIME100 AltitudeAI Recognition Just Shift Waystar Holding's (WAY) Investment Narrative?
Waystar Holding Corp. recently reported strong Q1 2026 results with US$313.87 million in revenue and US$43.28 million in net income, while reaffirming full-year revenue guidance. The company also gained recognition on the TIME100 Most Influential Companies list for its AltitudeAI platform, which is significantly impacting healthcare revenue cycle automation. This article explores how these developments influence Waystar's investment outlook, emphasizing the role of AI in its continued growth despite ongoing risks related to integration, debt, and potential margin pressures.
Waystar Holding Corp. (NASDAQ:WAY) Receives Average Recommendation of "Buy" from Brokerages
Waystar Holding Corp. (NASDAQ:WAY) has received an average "Buy" rating from 23 analysts, with a mean 12-month price target of $36.14. The company recently reported strong Q1 results, beating EPS and revenue estimates, and provided positive FY2026 EPS guidance. Despite trading below analyst targets, major institutional investors hold significant stakes in the firm.
Waystar Holding Jumps 6.1% After Citigroup Maintains Buy
Waystar Holding Corp. shares rose 6.1% to $21.12 after Citigroup maintained its "Buy" rating, despite cutting the price target from $35 to $30. Investors focused on the reiterated Buy rating as a vote of confidence, overlooking the reduced target. The company operates in the healthcare technology sector, providing revenue cycle management solutions.
WAY Earning Date, Earning Analysis and Earning Prediction
This article provides an earnings analysis and prediction for WAY, including past quarterly results and future forecasts. It details revenue and EPS figures, analyst estimates, and how the stock price typically reacts around earnings announcements. The analysis also highlights the correlation between forecast revisions and stock movements, offering insights for investors.
Waystar Holding Corp. boosts OSF HealthCare financial performance 50 percent as query rates surge 76 percent
Waystar Holding Corp. has significantly improved OSF HealthCare's financial performance by 50% and increased query rates by 76% through its clinical documentation improvement (CDI) solution. These advancements enabled OSF HealthCare to exceed its financial goals for three consecutive quarters. Waystar continues to push AI and automation in healthcare revenue cycle management, holding forums to discuss industry challenges and solutions.
Waystar (NASDAQ:WAY) Sets New 52-Week Low - Time to Sell?
Waystar (NASDAQ:WAY) shares recently hit a new 52-week low of $19.78, trading down 3.5% from its previous close, despite analysts maintaining a "Buy" consensus rating and an average price target of $36.14. The company reported strong Q1 earnings with EPS of $0.42 and revenue of $313.9 million, exceeding estimates, and provided positive FY2026 guidance. While institutional investors have shown mixed activity, some increasing their stakes, the stock's recent performance suggests a potential buying opportunity for investors looking at its long-term growth prospects as a healthcare revenue cycle management provider.
Impressive Earnings May Not Tell The Whole Story For Waystar Holding (NASDAQ:WAY)
Despite Waystar Holding Corp.'s strong reported profits, a deeper analysis suggests that dilution from new share issuance may be masking underlying earnings power. Over the last year, the company issued 11% more shares, leading to less impressive EPS growth (330%) compared to net profit growth (384%). This dilution indicates that individual shareholders are receiving a smaller portion of the company's overall profit.
Waystar Holding Corp. introduces advanced software to cut manual work in healthcare
Waystar Holding Corp. is showcasing its AI-powered software solutions at the eClinicalWorks Health Center Summit in Boston to reduce manual tasks, prevent denials, and boost productivity for healthcare providers. The company encourages attendees to visit their booth for demonstrations, reflecting its ongoing efforts to integrate AI into healthcare revenue cycle management. These efforts follow previous presentations of their AI tools at the THRIVE Healthcare Summit and discussions with industry executives on scaling AI technology.
Truist Financial Keeps Their Buy Rating on Waystar Holding Corp. (WAY)
Truist Financial analyst Jailendra Singh reiterated a Buy rating on Waystar Holding Corp. (WAY) with a $38.00 price target. This follows Waystar's recent earnings report, showing increased revenue and net profit compared to the previous year. While TD Cowen also issued a Buy rating, Morgan Stanley maintained a Hold rating on the stock.
TIME adds healthcare software firm Waystar to its 100 most influential list
Waystar (Nasdaq: WAY), a healthcare payment software provider, has been named to the TIME100 Most Influential Companies list and received the TIME Impact in AI award. The recognition highlights the effectiveness of its Waystar AltitudeAI™ platform, which has prevented $15.5 billion in denied claims and reduced denial appeal times by 90%. Waystar is accelerating its vision for an autonomous revenue cycle through new agentic AI capabilities and an expanded collaboration with Google Cloud.
UBS Group AG Sells 1,255,947 Shares of Waystar Holding Corp. $WAY
UBS Group AG reduced its stake in Waystar Holding Corp. by 35.2% in the fourth quarter, selling over 1.25 million shares. Despite Waystar beating Q1 earnings estimates and emphasizing AI initiatives, analysts have trimmed price targets due to management's conservative FY2026 revenue guidance and flat Q2 sequential growth projections. The stock currently holds a "Moderate Buy" consensus rating with an average price target of $36.38.
Waystar signals 2026 revenue of $1.274B-$1.294B while shifting Q2 sequential growth to flat-1%
Waystar has projected its revenue for 2026 to be between $1.274 billion and $1.294 billion. The company also announced a shift in its sequential growth for the second quarter to be flat to 1%.
